BamSEC and AlphaSense Join Forces
Learn More

Eagle Pharmaceuticals Inc.

Formerly NASDAQ: EGRX
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 5 pages November 8, 2024 Christopher Krawtschuk 490 Foothill Road Bridgewater, Nj 08807 Re: Offer of Employment
12/34/56
EX-10.2
from 8-K 3 pages March 8, 2024 via Email Steven Ratoff
12/34/56
EX-10.1
from 8-K 14 pages March 8, 2024 Brian Cahill via Email Dear Brian: This Letter Sets Forth the Substance of the Separation Agreement (The “Agreement”) That Eagle Pharmaceuticals, Inc. (The “Company”) Is Offering to You to Aid in Your Employment Transition
12/34/56
EX-10.1
from 8-K/A 3 pages December 21, 2023 via Email Michael Graves
12/34/56
EX-10.1
from 8-K 17 pages November 27, 2023 Scott Tarriff via Email
12/34/56
EX-10.1
from 8-K 22 pages Certain Information Marked as [***] Has Been Excluded From This Exhibit Because It Is Both (I) Not Material and (II) the Type That the Registrant Treats as Private or Confidential. Settlement and License Agreement
12/34/56
EX-10.1
from 8-K 2 pages Amendment to Development and Licensing Agreement
12/34/56
EX-10.1
from 8-K 20 pages Eagle Pharmaceuticals, Inc. Amended and Restated Severance Benefit Plan
12/34/56
EX-10.4
from 10-Q 49 pages Settlement and License Agreement
12/34/56
EX-10.2
from 8-K 40 pages Security Purchase Option Agreement
12/34/56
EX-10.3
from 10-Q 16 pages Dated June 9, 2022 Guarantee and Indemnity Between Eagle Pharmaceuticals, Inc. and Cosmo Technologies Ltd
12/34/56
EX-10.1
from 8-K 33 pages Securities Purchase Agreement
12/34/56
EX-10.4
from 8-K 5 pages Lock-Up Agreement
12/34/56
EX-10.3
from 8-K 5 pages Lock-Up Agreement
12/34/56
EX-10.2
from 8-K 12 pages Deed of Irrevocable Undertaking – Director
12/34/56
EX-10.1
from 8-K 11 pages Deed of Irrevocable Undertaking – Shareholder
12/34/56
EX-10.2
from 10-Q 43 pages License Agreement Between Aop Orphan Pharmaceuticals Gmbh and Eagle Pharmaceuticals, Inc. License Agreement
12/34/56
EX-10.1
from 10-Q 52 pages License Agreement Between Eagle Pharmaceuticals, Inc. and Combioxin SA
12/34/56
EX-10.30
from 10-K 8 pages Eagle Pharmaceuticals, Inc. Performance Stock Unit Grant Notice
12/34/56
EX-10.29
from 10-K 9 pages Eagle Pharmaceuticals, Inc. Performance Stock Unit Grant Notice
12/34/56